Back to Alk-Positive Large B-Cell Lymphoma

Alk-Positive Large B-Cell Lymphoma — Clinical Trials

MONDO:00182254 active·3 recruitingLast updated: Mar 18, 2026, 8:48 PM

Trial Landscape

Alk-Positive Large B-Cell Lymphoma has an emerging clinical trial program, driven by drug treatment and biological therapy.

Recruiting

Active Trials

By Approach

Drug Treatment4

Biological Therapy3

Procedure2

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other2NIH1Industry1

Top Sponsors

Schrödinger, Inc.

Trial Locations

United States4 trials

France1 trial

Italy1 trial

Moldova1 trial

Poland1 trial

Romania1 trial

Spain1 trial

Ukraine1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Phase 2Recruiting

NCT06834373

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Sponsor:Mayo Clinic

United StatesStarted: Apr 2025Est. completion: Mar 2027Updated: Jan 2026

Phase 1Recruiting

NCT04231877

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Sponsor:University of Washington

United StatesStarted: Oct 2020Est. completion: Dec 2031Updated: Mar 2026

Phase 1Recruiting

NCT05544019

Study of SGR-1505 in Mature B-Cell Neoplasms

Sponsor:Schrödinger, Inc.

United StatesStarted: Apr 2023Est. completion: Nov 2027Updated: Feb 2026

Phase 2Active, Not Recruiting

NCT03038672

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Dec 2018Est. completion: Oct 2026Updated: Nov 2025

Stay informed about clinical trials for Alk-Positive Large B-Cell Lymphoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 8:48 PM